Chapter 1 30 55. McKeigue PM, McAllister DA, Hutchinson SJ, Robertson C, Stockton D, Colhoun HM. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study. The Lancet Respiratory Medicine 2022; 10(6): 566-72. 56. Cao Y, Wang J, Jian F, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 2022; 602(7898): 657-63. 57. Auvigne V, Vaux S, Strat YL, et al. Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study. eClinicalMedicine 2022; 48. 58. RIVM. Variants of the coronavirus SARS-CoV-2. Accessed 9 August 2022. 59. Tijdlijn van coronamaatregelen. Ministry of Health, Welfare and Sport Vol. 2022: Government of the Netherlands, 2022. 60. Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med 2021; 268: 113426-. 61. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. (2589-5370 (Electronic)). 62. Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nature Reviews Disease Primers 2016; 2(1): 16090. 63. Hickie I, Davenport T Fau - Wakefield D, Wakefield D Fau - Vollmer-Conna U, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. (1756-1833 (Electronic)). 64. Excellence NIfHaC. COVID-19 rapid guideline: managing the longterm effects of COVID-19 (NG188) - Evidence reviews 2 and 3: prevalence, 2020 18 December 2020. 65. WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization (WHO) clinical case definition working group on post COVID-19 condition 2021. 66. Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nature Communications 2022; 13(1): 1812. 67. Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nature Medicine 2021; 27(9): 1607-13. 68. Rajan SK, Kamlesh; Alwan, Nisreen; Steves, Claire; Greenhalgh, Trish; MacDermott, Nathalie; Sagan, Anna; McKee, Martin. In the wake of the pandemic: Preparing for Long COVID - Policy Brief 39. Geneva, Switzerland: World Health Organization, 2021. 69. CBS. 3. Achtergrond van de nieuwe indeling. Available at: https://www.cbs.nl/nl-nl/longread/ statistische-trends/2022/nieuwe-indeling-bevolking-naar-herkomst/3-achtergrond-van-denieuwe-indeling. Accessed 29 May. 70. CBS. 4.2.1 Vier niveaus. Available at: https://www.cbs.nl/nl-nl/longread/statistische-trends/2022/ nieuwe-indeling-bevolking-naar-herkomst/4-de-nieuwe-indeling-naar-geboren-in-nederlanden-herkomstland. Accessed 29 May 71. Campman SLB, A.; Coyer, L.; Schinkel, J.; Agyemang, C.; Galenkamp, H.; Koopman, A.; Chilunga, F.; Schim van der Loeff, M.; van Houtum, L.; Leenstra, T.; Stronks, K.; Prins, M. SARS-CoV-2 vaccination uptake in six ethnic groups living in Amsterdam, the Netherlands (P2729). 33rd European Conferences for Clinical Microbiology and Infectious Diseases (ECCMID). Copenhagen, 2023. 72. Chilunga FA-OX, Stoeldraijer L, Agyemang C, Stronks K, Harmsen C, Kunst AE. Inequalities in COVID-19 deaths by migration background during the first wave, interwave period and second wave of the COVID-19 pandemic: a closed cohort study of 17 million inhabitants of the Netherlands. LID - jech-2022-219521 [pii] LID - 10.1136/jech-2022-219521 [doi]. (1470-2738 (Electronic)).
RkJQdWJsaXNoZXIy MTk4NDMw